Greenbrook TMS Inc.
Greenbrook TMS Inc. GBNH Peers
See (GBNH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GBNH | $0.12 | -40.69% | 5.5M | -0.06 | -$2.07 | N/A |
| HCA | $378.04 | -2.95% | 91B | 16.80 | $22.51 | +0.73% |
| FMS | $28.32 | -1.56% | 16.6B | 23.41 | $1.21 | +2.77% |
| THC | $172.22 | -2.94% | 16B | 11.05 | $15.58 | N/A |
| SOLV | $78.25 | +0.46% | 13.5B | 36.05 | $2.17 | N/A |
| EHC | $118.88 | -1.28% | 12B | 24.47 | $4.86 | +0.57% |
| UHS | $184.47 | -2.37% | 11.9B | 10.36 | $17.81 | +0.43% |
| DVA | $142.56 | -2.83% | 10.8B | 14.15 | $10.08 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $148.91 | -1.25% | 8.6B | 28.10 | $5.30 | +0.17% |
Stock Comparison
GBNH vs HCA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, HCA has a market cap of 91B. Regarding current trading prices, GBNH is priced at $0.12, while HCA trades at $378.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas HCA's P/E ratio is 16.80. In terms of profitability, GBNH's ROE is +15.74%, compared to HCA's ROE of -2.36%. Regarding short-term risk, GBNH is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs FMS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, FMS has a market cap of 16.6B. Regarding current trading prices, GBNH is priced at $0.12, while FMS trades at $28.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas FMS's P/E ratio is 23.41. In terms of profitability, GBNH's ROE is +15.74%, compared to FMS's ROE of +0.04%. Regarding short-term risk, GBNH is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs THC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, THC has a market cap of 16B. Regarding current trading prices, GBNH is priced at $0.12, while THC trades at $172.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas THC's P/E ratio is 11.05. In terms of profitability, GBNH's ROE is +15.74%, compared to THC's ROE of +0.37%. Regarding short-term risk, GBNH is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SOLV Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, GBNH is priced at $0.12, while SOLV trades at $78.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SOLV's P/E ratio is 36.05. In terms of profitability, GBNH's ROE is +15.74%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, GBNH is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs EHC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, EHC has a market cap of 12B. Regarding current trading prices, GBNH is priced at $0.12, while EHC trades at $118.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas EHC's P/E ratio is 24.47. In terms of profitability, GBNH's ROE is +15.74%, compared to EHC's ROE of +0.25%. Regarding short-term risk, GBNH is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs UHS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, UHS has a market cap of 11.9B. Regarding current trading prices, GBNH is priced at $0.12, while UHS trades at $184.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas UHS's P/E ratio is 10.36. In terms of profitability, GBNH's ROE is +15.74%, compared to UHS's ROE of +0.18%. Regarding short-term risk, GBNH is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs DVA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, DVA has a market cap of 10.8B. Regarding current trading prices, GBNH is priced at $0.12, while DVA trades at $142.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas DVA's P/E ratio is 14.15. In terms of profitability, GBNH's ROE is +15.74%, compared to DVA's ROE of +3.94%. Regarding short-term risk, GBNH is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs OSH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, GBNH is priced at $0.12, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas OSH's P/E ratio is -17.65. In terms of profitability, GBNH's ROE is +15.74%, compared to OSH's ROE of +4.64%. Regarding short-term risk, GBNH is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ENSG Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ENSG has a market cap of 8.6B. Regarding current trading prices, GBNH is priced at $0.12, while ENSG trades at $148.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ENSG's P/E ratio is 28.10. In terms of profitability, GBNH's ROE is +15.74%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, GBNH is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CHE Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CHE has a market cap of 6.9B. Regarding current trading prices, GBNH is priced at $0.12, while CHE trades at $471.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CHE's P/E ratio is 23.00. In terms of profitability, GBNH's ROE is +15.74%, compared to CHE's ROE of +0.26%. Regarding short-term risk, GBNH is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs LHCG Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, GBNH is priced at $0.12, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas LHCG's P/E ratio is 82.83. In terms of profitability, GBNH's ROE is +15.74%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, GBNH is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs OPCH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, OPCH has a market cap of 5.1B. Regarding current trading prices, GBNH is priced at $0.12, while OPCH trades at $31.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas OPCH's P/E ratio is 24.82. In terms of profitability, GBNH's ROE is +15.74%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, GBNH is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AMED Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AMED has a market cap of 3.1B. Regarding current trading prices, GBNH is priced at $0.12, while AMED trades at $95.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AMED's P/E ratio is 35.40. In terms of profitability, GBNH's ROE is +15.74%, compared to AMED's ROE of +0.10%. Regarding short-term risk, GBNH is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SGRY Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SGRY has a market cap of 2.8B. Regarding current trading prices, GBNH is priced at $0.12, while SGRY trades at $22.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SGRY's P/E ratio is -14.39. In terms of profitability, GBNH's ROE is +15.74%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, GBNH is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ACHC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ACHC has a market cap of 2.1B. Regarding current trading prices, GBNH is priced at $0.12, while ACHC trades at $23.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ACHC's P/E ratio is 11.37. In terms of profitability, GBNH's ROE is +15.74%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, GBNH is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ADUS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ADUS has a market cap of 2B. Regarding current trading prices, GBNH is priced at $0.12, while ADUS trades at $110.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ADUS's P/E ratio is 25.00. In terms of profitability, GBNH's ROE is +15.74%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, GBNH is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SEM Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SEM has a market cap of 1.9B. Regarding current trading prices, GBNH is priced at $0.12, while SEM trades at $15.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SEM's P/E ratio is 24.40. In terms of profitability, GBNH's ROE is +15.74%, compared to SEM's ROE of +0.10%. Regarding short-term risk, GBNH is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ARDT Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ARDT has a market cap of 1.9B. Regarding current trading prices, GBNH is priced at $0.12, while ARDT trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ARDT's P/E ratio is 7.99. In terms of profitability, GBNH's ROE is +15.74%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, GBNH is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs LFST Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, LFST has a market cap of 1.9B. Regarding current trading prices, GBNH is priced at $0.12, while LFST trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas LFST's P/E ratio is -53.11. In terms of profitability, GBNH's ROE is +15.74%, compared to LFST's ROE of -0.02%. Regarding short-term risk, GBNH is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AMEH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, GBNH is priced at $0.12, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AMEH's P/E ratio is 39.25. In terms of profitability, GBNH's ROE is +15.74%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, GBNH is more volatile compared to AMEH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs NHC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, NHC has a market cap of 1.7B. Regarding current trading prices, GBNH is priced at $0.12, while NHC trades at $108.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas NHC's P/E ratio is 15.73. In terms of profitability, GBNH's ROE is +15.74%, compared to NHC's ROE of +0.11%. Regarding short-term risk, GBNH is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs BKD Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, BKD has a market cap of 1.6B. Regarding current trading prices, GBNH is priced at $0.12, while BKD trades at $6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas BKD's P/E ratio is -6.61. In terms of profitability, GBNH's ROE is +15.74%, compared to BKD's ROE of -0.96%. Regarding short-term risk, GBNH is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs BKDT Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, GBNH is priced at $0.12, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas BKDT's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, GBNH is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ASTH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ASTH has a market cap of 1.2B. Regarding current trading prices, GBNH is priced at $0.12, while ASTH trades at $24.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ASTH's P/E ratio is 33.74. In terms of profitability, GBNH's ROE is +15.74%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, GBNH is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs USPH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, GBNH is priced at $0.12, while USPH trades at $80.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas USPH's P/E ratio is 36.98. In terms of profitability, GBNH's ROE is +15.74%, compared to USPH's ROE of +0.06%. Regarding short-term risk, GBNH is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs MD Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, MD has a market cap of 1.2B. Regarding current trading prices, GBNH is priced at $0.12, while MD trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas MD's P/E ratio is -13.78. In terms of profitability, GBNH's ROE is +15.74%, compared to MD's ROE of -0.11%. Regarding short-term risk, GBNH is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs HCSG Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, HCSG has a market cap of 1.1B. Regarding current trading prices, GBNH is priced at $0.12, while HCSG trades at $14.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas HCSG's P/E ratio is 27.13. In terms of profitability, GBNH's ROE is +15.74%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, GBNH is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AGL Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AGL has a market cap of 983.1M. Regarding current trading prices, GBNH is priced at $0.12, while AGL trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AGL's P/E ratio is -3.83. In terms of profitability, GBNH's ROE is +15.74%, compared to AGL's ROE of -0.44%. Regarding short-term risk, GBNH is more volatile compared to AGL. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs PNTG Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, PNTG has a market cap of 891.4M. Regarding current trading prices, GBNH is priced at $0.12, while PNTG trades at $25.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas PNTG's P/E ratio is 34.03. In terms of profitability, GBNH's ROE is +15.74%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, GBNH is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AVAH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AVAH has a market cap of 868.2M. Regarding current trading prices, GBNH is priced at $0.12, while AVAH trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AVAH's P/E ratio is 148.33. In terms of profitability, GBNH's ROE is +15.74%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, GBNH is more volatile compared to AVAH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AMN Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AMN has a market cap of 843.4M. Regarding current trading prices, GBNH is priced at $0.12, while AMN trades at $22.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AMN's P/E ratio is -5.09. In terms of profitability, GBNH's ROE is +15.74%, compared to AMN's ROE of -0.21%. Regarding short-term risk, GBNH is more volatile compared to AMN. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TALKW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TALKW has a market cap of 618.3M. Regarding current trading prices, GBNH is priced at $0.12, while TALKW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TALKW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, GBNH is more volatile compared to TALKW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs INNV Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, INNV has a market cap of 563M. Regarding current trading prices, GBNH is priced at $0.12, while INNV trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas INNV's P/E ratio is -17.37. In terms of profitability, GBNH's ROE is +15.74%, compared to INNV's ROE of -0.12%. Regarding short-term risk, GBNH is more volatile compared to INNV. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CYH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CYH has a market cap of 481.2M. Regarding current trading prices, GBNH is priced at $0.12, while CYH trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CYH's P/E ratio is -0.93. In terms of profitability, GBNH's ROE is +15.74%, compared to CYH's ROE of +0.30%. Regarding short-term risk, GBNH is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SNDA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SNDA has a market cap of 471.1M. Regarding current trading prices, GBNH is priced at $0.12, while SNDA trades at $24.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SNDA's P/E ratio is -6.88. In terms of profitability, GBNH's ROE is +15.74%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, GBNH is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AUNA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AUNA has a market cap of 465.5M. Regarding current trading prices, GBNH is priced at $0.12, while AUNA trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AUNA's P/E ratio is 9.68. In terms of profitability, GBNH's ROE is +15.74%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, GBNH is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TALK Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TALK has a market cap of 441.7M. Regarding current trading prices, GBNH is priced at $0.12, while TALK trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TALK's P/E ratio is 132.00. In terms of profitability, GBNH's ROE is +15.74%, compared to TALK's ROE of -0.04%. Regarding short-term risk, GBNH is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CCRN Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CCRN has a market cap of 429.1M. Regarding current trading prices, GBNH is priced at $0.12, while CCRN trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CCRN's P/E ratio is -24.24. In terms of profitability, GBNH's ROE is +15.74%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, GBNH is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AONC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AONC has a market cap of 402.5M. Regarding current trading prices, GBNH is priced at $0.12, while AONC trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AONC's P/E ratio is -15.51. In terms of profitability, GBNH's ROE is +15.74%, compared to AONC's ROE of +0.25%. Regarding short-term risk, GBNH is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs EHAB Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, EHAB has a market cap of 389.9M. Regarding current trading prices, GBNH is priced at $0.12, while EHAB trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas EHAB's P/E ratio is -2.78. In terms of profitability, GBNH's ROE is +15.74%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, GBNH is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AIRS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AIRS has a market cap of 322.1M. Regarding current trading prices, GBNH is priced at $0.12, while AIRS trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AIRS's P/E ratio is -17.79. In terms of profitability, GBNH's ROE is +15.74%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, GBNH is more volatile compared to AIRS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CMPS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CMPS has a market cap of 314.8M. Regarding current trading prices, GBNH is priced at $0.12, while CMPS trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CMPS's P/E ratio is -1.70. In terms of profitability, GBNH's ROE is +15.74%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, GBNH is more volatile compared to CMPS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TOIIW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TOIIW has a market cap of 262.9M. Regarding current trading prices, GBNH is priced at $0.12, while TOIIW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TOIIW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, GBNH is more volatile compared to TOIIW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TOI Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TOI has a market cap of 224.7M. Regarding current trading prices, GBNH is priced at $0.12, while TOI trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TOI's P/E ratio is -3.49. In terms of profitability, GBNH's ROE is +15.74%, compared to TOI's ROE of -4.83%. Regarding short-term risk, GBNH is more volatile compared to TOI. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CSU Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, GBNH is priced at $0.12, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CSU's P/E ratio is 0.67. In terms of profitability, GBNH's ROE is +15.74%, compared to CSU's ROE of +2.23%. Regarding short-term risk, GBNH is more volatile compared to CSU. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs JYNT Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, JYNT has a market cap of 180.4M. Regarding current trading prices, GBNH is priced at $0.12, while JYNT trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas JYNT's P/E ratio is -117.90. In terms of profitability, GBNH's ROE is +15.74%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, GBNH is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs BTMD Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, BTMD has a market cap of 160.8M. Regarding current trading prices, GBNH is priced at $0.12, while BTMD trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas BTMD's P/E ratio is 7.24. In terms of profitability, GBNH's ROE is +15.74%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, GBNH is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs DCGO Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, DCGO has a market cap of 155.6M. Regarding current trading prices, GBNH is priced at $0.12, while DCGO trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas DCGO's P/E ratio is -157.00. In terms of profitability, GBNH's ROE is +15.74%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, GBNH is more volatile compared to DCGO. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs FVE Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, GBNH is priced at $0.12, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas FVE's P/E ratio is -5.64. In terms of profitability, GBNH's ROE is +15.74%, compared to FVE's ROE of -0.15%. Regarding short-term risk, GBNH is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs KDLYW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, GBNH is priced at $0.12, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas KDLYW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, GBNH is more volatile compared to KDLYW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs MODV Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, MODV has a market cap of 45.1M. Regarding current trading prices, GBNH is priced at $0.12, while MODV trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas MODV's P/E ratio is -0.20. In terms of profitability, GBNH's ROE is +15.74%, compared to MODV's ROE of +6.87%. Regarding short-term risk, GBNH is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ALR Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, GBNH is priced at $0.12, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ALR's P/E ratio is -1.11. In terms of profitability, GBNH's ROE is +15.74%, compared to ALR's ROE of -0.15%. Regarding short-term risk, GBNH is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CCEL Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CCEL has a market cap of 41.2M. Regarding current trading prices, GBNH is priced at $0.12, while CCEL trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CCEL's P/E ratio is 509.90. In terms of profitability, GBNH's ROE is +15.74%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, GBNH is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs IMAC Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, GBNH is priced at $0.12, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas IMAC's P/E ratio is -2.27. In terms of profitability, GBNH's ROE is +15.74%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, GBNH is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs PIII Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, PIII has a market cap of 20.6M. Regarding current trading prices, GBNH is priced at $0.12, while PIII trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas PIII's P/E ratio is -0.12. In terms of profitability, GBNH's ROE is +15.74%, compared to PIII's ROE of -1.29%. Regarding short-term risk, GBNH is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AIH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, GBNH is priced at $0.12, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AIH's P/E ratio is -2.78. In terms of profitability, GBNH's ROE is +15.74%, compared to AIH's ROE of +1.16%. Regarding short-term risk, GBNH is more volatile compared to AIH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs AMS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, AMS has a market cap of 15.7M. Regarding current trading prices, GBNH is priced at $0.12, while AMS trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas AMS's P/E ratio is 11.58. In terms of profitability, GBNH's ROE is +15.74%, compared to AMS's ROE of +0.06%. Regarding short-term risk, GBNH is more volatile compared to AMS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CANO Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, GBNH is priced at $0.12, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CANO's P/E ratio is -0.01. In terms of profitability, GBNH's ROE is +15.74%, compared to CANO's ROE of -1.49%. Regarding short-term risk, GBNH is more volatile compared to CANO. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs FTRP Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, GBNH is priced at $0.12, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas FTRP's P/E ratio is -1.22. In terms of profitability, GBNH's ROE is +15.74%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, GBNH is more volatile compared to FTRP. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs NIVFW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, NIVFW has a market cap of 5.7M. Regarding current trading prices, GBNH is priced at $0.12, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas NIVFW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, GBNH is more volatile compared to NIVFW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs RHE Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, GBNH is priced at $0.12, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas RHE's P/E ratio is -1.79. In terms of profitability, GBNH's ROE is +15.74%, compared to RHE's ROE of +1.52%. Regarding short-term risk, GBNH is more volatile compared to RHE. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs MNDR Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, MNDR has a market cap of 4.8M. Regarding current trading prices, GBNH is priced at $0.12, while MNDR trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas MNDR's P/E ratio is -0.15. In terms of profitability, GBNH's ROE is +15.74%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, GBNH is more volatile compared to MNDR. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs ATIP Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, ATIP has a market cap of 4.4M. Regarding current trading prices, GBNH is priced at $0.12, while ATIP trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas ATIP's P/E ratio is -0.05. In terms of profitability, GBNH's ROE is +15.74%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, GBNH is more volatile compared to ATIP. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs IMACW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, GBNH is priced at $0.12, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas IMACW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, GBNH is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for GBNH.
GBNH vs SYRA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SYRA has a market cap of 1.2M. Regarding current trading prices, GBNH is priced at $0.12, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SYRA's P/E ratio is -0.32. In terms of profitability, GBNH's ROE is +15.74%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, GBNH is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs CCM Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, CCM has a market cap of 823.9K. Regarding current trading prices, GBNH is priced at $0.12, while CCM trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas CCM's P/E ratio is -0.57. In terms of profitability, GBNH's ROE is +15.74%, compared to CCM's ROE of +0.13%. Regarding short-term risk, GBNH is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs RHE-PA Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, GBNH is priced at $0.12, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, GBNH's ROE is +15.74%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, GBNH is more volatile compared to RHE-PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs BACK Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, BACK has a market cap of 189.2K. Regarding current trading prices, GBNH is priced at $0.12, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas BACK's P/E ratio is -0.01. In terms of profitability, GBNH's ROE is +15.74%, compared to BACK's ROE of +2.46%. Regarding short-term risk, GBNH is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs IONM Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, IONM has a market cap of 90.9K. Regarding current trading prices, GBNH is priced at $0.12, while IONM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas IONM's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to IONM's ROE of +0.75%. Regarding short-term risk, GBNH is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for GBNH.
GBNH vs PIIIW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, PIIIW has a market cap of 37.3K. Regarding current trading prices, GBNH is priced at $0.12, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, GBNH's ROE is +15.74%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, GBNH is more volatile compared to PIIIW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs NVOS Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, NVOS has a market cap of 5.9K. Regarding current trading prices, GBNH is priced at $0.12, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas NVOS's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, GBNH is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs HNGR Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas HNGR's P/E ratio is 19.71. In terms of profitability, GBNH's ROE is +15.74%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, GBNH is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TLMDW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TLMDW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, GBNH is more volatile compared to TLMDW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SLHGP Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, GBNH's ROE is +15.74%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, GBNH is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs SLHG Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas SLHG's P/E ratio is -1.48. In terms of profitability, GBNH's ROE is +15.74%, compared to SLHG's ROE of N/A. Regarding short-term risk, GBNH is more volatile compared to SLHG. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs DVCR Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas DVCR's P/E ratio is 28.34. In terms of profitability, GBNH's ROE is +15.74%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, GBNH is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs DCGOW Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas DCGOW's P/E ratio is N/A. In terms of profitability, GBNH's ROE is +15.74%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, GBNH is more volatile compared to DCGOW. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs NFH Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, NFH has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas NFH's P/E ratio is -19.75. In terms of profitability, GBNH's ROE is +15.74%, compared to NFH's ROE of -0.06%. Regarding short-term risk, GBNH is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TLMD Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TLMD's P/E ratio is -1.60. In terms of profitability, GBNH's ROE is +15.74%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, GBNH is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.
GBNH vs TVTY Comparison
GBNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBNH stands at 5.5M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, GBNH is priced at $0.12, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBNH currently has a P/E ratio of -0.06, whereas TVTY's P/E ratio is 19.06. In terms of profitability, GBNH's ROE is +15.74%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, GBNH is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for GBNH.